Total Revenue | 11,432 | 127 | 80 | Cost of Revenue | 3,244 | 49 | - | | Gross Profit | 8,188 | 78 | 80 | | | Operating Expenses | | Research Development | 51,614 | 72,019 | 61,994 | | Selling General and Administrative | 41,607 | 35,316 | 35,303 | | Non Recurring | (9,408) | 24,816 | 591 | | Others | 1,658 | 913 | 792 | | | | Total Operating Expenses | 85,471 | 133,064 | 98,680 | | | Operating Income or Loss | (77,283) | (132,986) | (98,600) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 42,583 | 9,627 | 7,363 | | Earnings Before Interest And Taxes | (34,697) | (123,281) | (91,237) | | Interest Expense | 145,332 | 14,827 | 44,582 | | Income Before Tax | (180,029) | (138,108) | (135,819) | | Income Tax Expense | - | - | - | | Minority Interest | 126 | 78 | - | | | | Net Income From Continuing Ops | (180,029) | (138,108) | (135,819) | | | Non-recurring Events | | Discontinued Operations | - | - | - | | Extraordinary Items | - | - | - | | Effect Of Accounting Changes | - | - | - | | Other Items | - | - | - | | | Net Income | (180,029) | (138,108) | (135,819) | Preferred Stock And Other Adjustments | (22,878) | (10,197) | - | | Net Income Applicable To Common Shares | ($202,907) | ($148,305) | ($135,819) |
|
|